Merck Sues To Stop Manufacture Of Generic Fosamax

Law360, New York (April 11, 2006, 12:00 AM EDT) -- In a move to protect its embattled market share for osteoporosis treatments, Merck and Co. Inc. has filed a lawsuit in federal court against Canadian generic drug manufacturer Apotex Inc. to stifle its generic version of Fosamax.

In the lawsuit, filed in U.S. District Court in Delaware, Merck accused Apotex of knowingly infringing nine of its patents for the drug and mirrors a number of other suits that ended last year with a decade being taken of the life of the patent.

The seeds for Merck’s...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.